Maureen Kipkoech

Ms. Maureen Kipkoech

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Heliyon
Verified
Journal Article
Open access
MKMaureen Kipkoech
Maureen Kipkoech
JMJudy Mwangi
Judy Mwangi
BKBenda Kithaka
Benda Kithaka
SKSerah Kimaru
Serah Kimaru
NKNdinda Kusu
Ndinda Kusu
FMFrancis Makokha
Francis Makokha
Globally, cancer is a major public health problem. There is a paucity of information regarding stigma and how it affects the cancer survivors' quality of life (QoL) in Kenya. In a recent report by Globocan, 42,116 new cases and 27,072 fatalities related to cancer were documented in Kenya in 2020. Cancer survivors are more likely to suffer physical and psychological disorders as a result of their poor QoL. The purpose of this study was to evaluate the knowledge, attitudes, and beliefs regarding the stigma associated with the disease as well as how it affects their QoL among a cohort of cancer survivors supported by the KILELE Health Association. This research used a cross-sectional design with both quantitative and qualitative methods. The study enrolled 45 cancer survivors from a cohort participating in the KILELE Health Association (KHA) survivors' program. The quantitative data were coded and analyzed using the 26th version of the Statistical Package for Social Sciences (SPSS). Utilizing content analysis, qualitative data was thematically evaluated. In accordance with the study's goals and key measures, the generated transcripts were organized into themes and sub-themes. Participants' mean age was 44.55 ± 9.89 years. Forty-two of the participants completed the survey and were thus included in the analysis. Cancer survivors reported experiencing low levels of stigma across the following dimensions: awkwardness (2.51 ± 0.75), severity (3.22 ± 1.29), financial discrimination (2.77 ± 1.17), personal responsibility (1.9 ± 1.38), avoidance (1.38 ± 0.68), and policy level stigmatization (5.09 ± 1.70). Awareness raising (97.62%), using communication channels (95.24%), advocacy, and lobbying (92.86%) were the most commonly stated strategies to change people's attitudes in terms of interventions to reduce stigma and improve QoL. Respondents in this study showed low levels of stigma, which may be due to the support they receive from the KILELE Health Association. Strategic steps in advocacy, publicity, and education are required to end stigmatization to promote awareness and pique people's interest in cancer survivorship. Further research with a larger sample size of cancer survivors from various settings is warranted.

20 May 2024 in Heliyon
Verified
Journal Article
Open access
MKMaureen Kipkoech
Maureen Kipkoech
KMKarani Magutah
Karani Magutah
D(Dominic Mogere (PhD)
Dominic Mogere (PhD)
JKJohn Kariuki
John Kariuki
KWKipyegon Willy
Kipyegon Willy
HCHarrison Chege
Harrison Chege
Only 12% of Kenyan women use breast cancer (BC)screening programs. Early identification is critical for reducing the condition's associated morbidity and mortality. Unfortunately, few studies have been conducted on the screening program's implementation and the causes for the low usage rates in Turbo Sub-County, Kenya. The purpose of this study was to learn about women of reproductive age's (WRA) practices, attitudes, and knowledge regarding BC screening programs, as well as to investigate the potential association between lifestyle factors and BC screening service utilization. Mixed-method approaches were used in an analytical cross-sectional study design. The study included 317 participants selected randomly. An interviewer-administered questionnaire was used to collect quantitative data while focus group discussion (FGD) and key informant interview (KII) guides were used for collecting qualitative data. The Statistical Package for Social Sciences (SPSS) version 26 was used to manage quantitative data, whereas NVivo version 12 was used to analyze qualitative data. Chi-square, Fisher's exact test, and multiple logistic regression were used to assess the degree of relationship between BC screening service uptake and independent variables. The qualitative data was transcribed verbatim, and the transcripts were automatically coded to generate themes. The participants' mean age was 30.14 (9.64). Breast cancer screening services were used by 10.21% of the population. Women who were aware of the signs and symptoms of BC were 71.5 times more likely to undergo screening than their counterparts. Similarly, those with positive attitudes toward BC and screening programs were 84 times more likely to get screened than those with negative attitudes. Breastfeeding increased the likelihood of BC screening by OR = 37 (95% CI: 0.00–0.32), physical activity by OR = 37 (95% CI: 0.00–0.25), and chronic illnesses by OR = 37 (95% CI: 0.00–0.17). Knowledge of signs and symptoms of BC and a positive attitude towards perceived barriers enhanced the probabilities of BC screening. Being physically active, breastfeeding, and having a chronic disease all increased the odds of BC screening uptake. To improve screening rates, it is necessary to provide sufficient information to those who are least likely to be screened.

4 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
MKMaureen Kipkoech
Maureen Kipkoech
JLJan Lubiński
Jan Lubiński
WMWojciech Marciniak
Wojciech Marciniak
RDRóża Derkacz
Róża Derkacz
TJTheron Johnson
Theron Johnson
VKVerena Katzke
Verena Katzke
Background/Objectives: Background: The International Agency for Research on Cancer has classified arsenic as a group 1 carcinogen of the lung, skin and bladder. Arsenic has been implicated in the pathogenesis of breast, prostate, and colorectal cancers; however, existing evidence is limited and inconsistent. Prospective studies, particularly those employing blood-based quantification of arsenic, remain scarce. This study aimed to address this gap by investigating the association between serum arsenic levels and breast, prostate, and colorectal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC) Heidelberg case–cohort. Methods: Serum arsenic levels were measured using inductively coupled mass spectrometry in 5360 participants aged 35–65 years, recruited between 1994 and 1998. Over a median follow-up of 18 years (IQR: 17–19), 685 incident cases of breast, 597 of prostate, and 284 of colorectal cancer occurred. Prentice-weighted Cox proportional hazards regression models with age as the underlying time scale were used to estimate hazard ratios and confidence intervals for associations between serum arsenic levels and cancer risk. Results: No statistically significant association was found between serum arsenic levels and breast cancer, either overall with HR 1.04 (95% Cl: 0.96–1.35) or in subgroups based on pre- and post-menopausal status, estrogen/progesterone status, or BMI. Similarly, serum arsenic levels were not statistically associated with prostate cancer of HR 0.91 (95% Cl: 0.72–1.14). In contrast, a significant association with colon cancer emerged in the second quartile with HR 0.12 (95% Cl: 0.02–0.61) and third quartile with HR 0.19 (95% Cl: 0.05–0.73) compared to the first quartile but not in rectal cancer. Conclusions: More comparative studies on the different arsenic media and arsenic speciation should be conducted to determine the impact of arsenic on these cancers.

30 April 2022 in International Journal of TROPICAL DISEASE & Health
Verified
Journal Article
Closed access
PDF file
MKMaureen Kipkoech
Maureen Kipkoech
JKJohn G. Kariuki
John G. Kariuki
DMDominic M. Mogere
Dominic M. Mogere
KMKarani Magutah
Karani Magutah
EJEsleen Jeruto
Esleen Jeruto
Aim: To determine the prevalence, socio-demographic, and health system factors influencing the uptake of breast cancer (BC) screening services among women of reproductive age (WRA). Methods: An analytical cross-sectional research design was used which employed mixed-methods approach. Multi-stage and purposive sampling techniques were used to select the study location and to recruit study participants. A semi-structured questionnaire was administered to WRA participants. A subset of respondents took part in the qualitative study. Results: The study sample was 317 WRA. The prevalence of uptake of BC screening services was 10.2%. Being employed (OR=5.6, 95% CI: 1.81-17.47) and earning a high income (OR=4.9, 95% CI: 1.22-19.47) increased the likelihood of uptake of BC screening services. The presence of outreach programs (OR=3.8, 95% CI: 0.07-0.97), reduced screening charges (OR=1.1, 95% CI: 2.22-4.30), reduced distance to the health facilities (OR=3.2, 95% CI: 1.07-9.51), and reduced waiting time (OR=3.3, 95% CI: 0.10-0.96) augmented the odds of uptake of BC screening services. Conclusion: The uptake of BC screening services was low (10.2%). Based on these findings, the government should subsidize screening services for low-income earners and the unemployed. The ministry of health should improve access to BC screening services and reduce waiting period.

12 November 2026 in BMC Cancer
Verified
Journal Article
Open access
MKMaureen Kipkoech
Maureen Kipkoech
CBCeline M Beck
Celine M Beck
AJAnna Jaeger
Anna Jaeger
KBKatrin Blume
Katrin Blume
JLJan Lubiński
Jan Lubiński
VKVerena Katzke
Verena Katzke
Purpose: Breast cancer is the most common cancer among women worldwide, yet the role of environmental toxicants remains unclear. Arsenic is an International Agency for Research on Cancer classified carcinogen linked to skin, lung, and bladder cancers. The relationship between dietary arsenic intake levels and blood arsenic concentrations, particularly across sexes, and the association between dietary arsenic intake and breast cancer remain understudied. This study aimed to address these gaps. Methods: Measurements of arsenic in foods collected from 1995 to 2022 in the German monitoring programme were used to estimate long-term dietary intake. Serum arsenic levels were measured using inductively coupled plasma mass spectrometry. Participants were aged 35–65 years; 2,674 non-cases were included in the arsenic intake-serum arsenic analysis, and 631 incident cases and 1,708 non-cases in the breast cancer analysis. Partial spearman’s rank correlation and logistic regression models assessed the association between dietary arsenic intake and serum arsenic levels. Prentice-weighted Cox proportional hazards models with age as underlying time scale were used to assess associations between dietary arsenic intake and breast cancer risk. Results: No association was observed between total or estimated inorganic arsenic intake and breast cancer risk (HR 1.1, 95% CI: 0.93–1.31; HR 0.9, 95% CI: 0.76–1.07), including in subgroup analyses by menopausal status (pre- and post-menopausal), estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status. Weak positive correlations were observed between total and estimated inorganic arsenic intake and serum arsenic concentrations (ρ = 0.20 and ρ = 0.07). However, regression analyses showed that total arsenic intake was associated with serum arsenic in both sexes (men: OR 3.48, 95% CI 2.33–5.22; women: OR 2.60, 95% CI 1.84–3.68), whereas estimated inorganic arsenic intake were associated only among women in the second and fourth quintiles (OR 1.53 [95% CI 1.10–2.14] and 1.90 [1.33–2.73], respectively). Conclusion: Dietary arsenic intake was not significantly associated with serum arsenic levels or incident breast cancer.

18 May 2026 in American Journal of Health Research
Verified
Journal Article
Closed access
PMPatrick Martin
Patrick Martin
AMAnn Munyaka
Ann Munyaka
JKJudith Kimiywe
Judith Kimiywe
MKMaureen Kipkoech
Maureen Kipkoech
Type 2 Diabetes Mellitus (T2DM) is a growing public health burden in Kenya and in the globe. Regular physical activity remains a key non-pharmacological strategy for improving glycemic outcomes in type 2 diabetic patients. This study assessed the relationship between physical activity and blood sugar control among adults with T2DM attending the outpatient diabetes clinic at Mama Lucy Kibaki Hospital, Nairobi, using a cross-sectional analytical design. Physical activity was assessed using the Global Physical Activity Questionnaire (GPAQ) and converted into MET-min/week categories; clinical glycemic indicators were obtained from patient records and validated where necessary, with quantitative analysis conducted in SPSS. Data from 116 participants was analyzed. Most participants were found to be overweight (41.4%) or obese (27.6%). Random blood sugar levels showed that 25.0% were within the normal range (<7.8 mmol/L), 38.8% were elevated (7.8–11.0 mmol/L), and 36.2% were in the diabetes range (≥11.1 mmol/L). Reported physical activity participation was also generally high with Metabolic Equivalent of Task (MET)-based categorization showing that 70.2% of the respondents had above average (≥3000 MET-min/week). A weak inverse association was as well observed between total energy expenditure (MET-min/week) and random blood sugar (r = −0.062). These findings suggest that although many patients report engaging in physical activity, the relationship with glycemic control may be limited or influenced by other factors such as weight status and broader lifestyle or clinical factors. Strengthening structured and monitored activity counselling alongside weight management support may therefore improve diabetes outcomes in this setting.